Call or click Are you eligible?
American English
American English
Español de América
Canadian English
Canadien Français
British English
Češka Čeština
Australian English

A clinical trial for
mild-to-moderate Alzheimer’s

Welcome to the MINDSET Alzheimer’s clinical trial—specifically designed for people with mild-to-moderate Alzheimer’s disease who are currently taking donepezil (Aricept®).

The MINDSET study is evaluating an investigational treatment for mild-to-moderate Alzheimer’s disease (known as RVT-101) that is taken together with the medication donepezil (Aricept®). In a previous study the combination of RVT-101 and donepezil was observed to provide statistically significant benefits on measurements of study participants’ cognition and ability to perform daily living activities, as compared to donepezil alone.

Join us and see if together we can make a difference in developing new treatments for Alzheimer’s disease: Learn more

Take the first step now:

or call